Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2018, Vol. 45 Issue (1): 98-101    DOI: 10.12891/ceog3783.2018
Original Research Previous articles | Next articles
Placental expression of retinol-binding protein 4 in patients with preeclampsia
E. Shim1, J.Y. Park2, H.J. Seol2, *()
1 Department of Medicine, Graduate School, Kyung Hee University, Seoul, Republic of Korea
2 Department of Obstetrics & Gynecology, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose of investigation: The aim of this study was to investigate retinol-binding protein 4 (RBP4) expression in the placenta of patients with preeclampsia and in normal pregnant women in the third trimester of pregnancy. Materials and Methods: Sixteen patients with preeclampsia and 11 normal healthy pregnant women were included. Placental RBP4 mRNA levels were quantified by real-time polymerase chain reaction (RT-PCR) and RBP4 protein expression in placental tissues was determined by western blot analysis and immunofluorescence. Results: Placental RBP4 mRNA expression was increased in patients with preeclampsia compared to normal controls. No association was observed between placental RBP4 mRNA expression and maternal body mass index or neonatal weight. Conclusion: Placental RBP4 expression was upregulated in patients with preeclampsia. This result suggested that placental RBP4 may play a role in exaggerated insulin resistance in preeclampsia.
Key words:  Retinol-binding protein 4      Placenta      Preeclampsia     
Published:  10 February 2018     
*Corresponding Author(s):  H.J. SEOL     E-mail:  seolhj@khu.ac.kr

Cite this article: 

E. Shim, J.Y. Park, H.J. Seol. Placental expression of retinol-binding protein 4 in patients with preeclampsia. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 98-101.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3783.2018     OR     https://ceog.imrpress.com/EN/Y2018/V45/I1/98

[1] G. Garuti, E. Castellacci, S. Calabrese, S. Calzolari. Hysteroscopic removal of retained products of conception withenhanced vascularity: a study of reliability[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 472-477.
[2] H.M. Kim, Y.S. Choo, W.J. Seong. Serum NT-proBNP levels as a marker for cardiopulmonary function in preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 511-515.
[3] H. Yolli, M.E. Demir, R. Yildizhan. Neutrophil gelatinase associated lipocalin-2 (Ngal) levels in preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 519-523.
[4] J.Y. Yan, P.P. Chen, L.L. Jiang, H.L. Zhang, Q. Han, R.X. Chen, Q.J. Zhang. Exploration on the relationship between hypoxia inducible factor-1α and morbidly adherent placenta[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 565-570.
[5] K. Tamura, H. Takahashi, S. Uchida, M. Ogoyama, R. Usui, S. Matsubara. Intrauterine balloon failure: unrecognized placenta accreta spectrum disorders[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 405-408.
[6] A.E. Kholeif, M.Y. Khamis, S. Eltabakh, R.S. Swilam, A. Elhabashy, R. EISherif. Prediction of severity of preeclampsia in Egyptian patients: role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and C-reactive protein[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 183-188.
[7] H.Y. Zhang, Y. Wu, R. Guo, M. Huang, Y. Ling, Y.H. Huang. Less Residual placental blood volume left when cord pulsation ceases than when early cord clamping at 60 seconds[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 202-207.
[8] Y. Tian, H. Luo, M. He. Effects of marginal umbilical cord insertion on the prognosis of fetus[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 234-237.
[9] K. Relakis, A. Pontikaki, I. Kosmas, S. Sifakis. Bilateral ascending uterine arteries ligation for conservative management of complete placenta previa: three case reports[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 144-146.
[10] H. Takahashi, Y. Baba, M. Ogoyama, H. Suzuki, A. Ohkuchi, R. Usui, S. Matsubara. Does previous cesarean section per se, especially its number, increase the risk of allogeneic blood transfusion at cesarean section for placenta previa?[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 41-46.
[11] A. Komatsu, K. Kawakami, H. Koike, T. Nagamatsu, Y. Osuga, T. Fujii. Uterine torsion in the second trimester of pregnancy with a large leiomyoma identified in a cesarean section for abruptio placentae: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 1026-1027.
[12] Z.R. Zheng, X. Xie, Y. Hou, P. Xie, X. Yu, L. Xie. Intraoperative infrarenal aortic balloon occlusion in pregnancies with placenta accreta, increta, and percreta[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 704-708.
[13] J. Yoon Park, S.W. Lee, K.J. Oh, J.-S. Hong. High mean blood pressure during the first trimester is predictive of future preeclampsia development in healthy pregnant women: a cohort study in Korea[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 770-775.
[14] M.L. Kozakiewicz, J.F. Nitsche, P.W. Whitecar, B.C. Brost. En bloc hysterectomy for treatment of symptomatic cervical varix in the early second trimester[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 661-662.
[15] Y.E. Purut, E.E. Buyukbayrak, F. Ercan, A. Orcun, M. Menke, A.Y. Karageyim Karsidag. Do first trimester maternal serum follistatin like 3 levels predict preeclampsia and/or related adverse pregnancy outcomes?[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 195-200.
No Suggested Reading articles found!